IndraLab

Statements


Drug inhibits NLRP3. 2 / 2
| 2

eidos
"In clinic settings , drugs directed to inhibit NLRP3 or IL-1beta are now being utilized for numerous autoimmune diseases , however not enough clinical research has supported the use of such treatments in viral infection ."

eidos
"NLRP3 itself can be inhibited by drugs such as MCC-950 , which has also shown efficacy in models of cardiac ischemia , aortic disease , and other inflammatory conditions ( 53 , 54 ) ."